475 related articles for article (PubMed ID: 22593567)
1. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
Ammann J; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
[TBL] [Abstract][Full Text] [Related]
2. Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones.
Ammann D; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):381-9. PubMed ID: 22593565
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jul; 47(7):825-35. PubMed ID: 22791249
[TBL] [Abstract][Full Text] [Related]
4. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
Shanks KG; Dahn T; Behonick G; Terrell A
J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
[TBL] [Abstract][Full Text] [Related]
5. Identification and quantification of 30 antipsychotics in blood using LC-MS/MS.
Saar E; Gerostamoulos D; Drummer OH; Beyer J
J Mass Spectrom; 2010 Aug; 45(8):915-25. PubMed ID: 20648676
[TBL] [Abstract][Full Text] [Related]
6. Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, "spice" and stimulants in oral fluid.
Strano-Rossi S; Anzillotti L; Castrignanò E; Romolo FS; Chiarotti M
J Chromatogr A; 2012 Oct; 1258():37-42. PubMed ID: 22939380
[TBL] [Abstract][Full Text] [Related]
7. Detection of gamma-hydroxybutyrate in hair: validation of GC-MS and LC-MS/MS methods and application to a real case.
Bertol E; Argo A; Procaccianti P; Vaiano F; Di Milia MG; Furlanetto S; Mari F
J Pharm Biomed Anal; 2012 Nov; 70():518-22. PubMed ID: 22884787
[TBL] [Abstract][Full Text] [Related]
8. Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry.
Pasin D; Bidny S; Fu S
J Anal Toxicol; 2015 Apr; 39(3):163-71. PubMed ID: 25552261
[TBL] [Abstract][Full Text] [Related]
9. Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework.
Shanks KG; Dahn T; Terrell AR
J Anal Toxicol; 2012 Apr; 36(3):145-52. PubMed ID: 22417829
[TBL] [Abstract][Full Text] [Related]
10. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
[TBL] [Abstract][Full Text] [Related]
11. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS.
Oiestad EL; Johansen U; Christophersen AS; Karinen R
Bioanalysis; 2013 Sep; 5(18):2257-68. PubMed ID: 24053241
[TBL] [Abstract][Full Text] [Related]
12. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.
Musah RA; Domin MA; Walling MA; Shepard JR
Rapid Commun Mass Spectrom; 2012 May; 26(9):1109-14. PubMed ID: 22467461
[TBL] [Abstract][Full Text] [Related]
13. A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry.
Freijo TD; Harris SE; Kala SV
J Anal Toxicol; 2014 Oct; 38(8):466-78. PubMed ID: 25217534
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples.
Dresen S; Kneisel S; Weinmann W; Zimmermann R; Auwärter V
J Mass Spectrom; 2011 Feb; 46(2):163-71. PubMed ID: 21259394
[TBL] [Abstract][Full Text] [Related]
15. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry.
Hutter M; Kneisel S; Auwärter V; Neukamm MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():95-101. PubMed ID: 22835826
[TBL] [Abstract][Full Text] [Related]
16. Quantification of selected synthetic cannabinoids and Δ9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.
de Castro A; Piñeiro B; Lendoiro E; Cruz A; López-Rivadulla M
J Chromatogr A; 2013 Jun; 1295():99-106. PubMed ID: 23680386
[TBL] [Abstract][Full Text] [Related]
17. Scheduled multiple reaction monitoring algorithm as a way to analyse new designer drugs combined with synthetic cannabinoids in human serum with liquid chromatography-tandem mass spectrometry.
Dziadosz M; Weller JP; Klintschar M; Teske J
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 929():84-9. PubMed ID: 23669607
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine--an Australian perspective.
de Jager AD; Warner JV; Henman M; Ferguson W; Hall A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():22-31. PubMed ID: 22521213
[TBL] [Abstract][Full Text] [Related]
19. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
[TBL] [Abstract][Full Text] [Related]
20. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
